Artykuły w czasopismach na temat „Antimycobacterial Susceptibility Using BACTEC”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Antimycobacterial Susceptibility Using BACTEC”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Hannan, Abdul, Saira Munir, Muhammad Usman Arshad, and Nabila Bashir. "In Vitro Antimycobacterial Activity of Pakistani Beri Honey Using BACTEC MGIT 960." International Scholarly Research Notices 2014 (October 7, 2014): 1–4. http://dx.doi.org/10.1155/2014/490589.
Pełny tekst źródłaMoore, Andrea V., Scott M. Kirk, Steven M. Callister, Gerald H. Mazurek, and Ronald F. Schell. "Safe Determination of Susceptibility of Mycobacterium tuberculosis to Antimycobacterial Agents by Flow Cytometry." Journal of Clinical Microbiology 37, no. 3 (1999): 479–83. http://dx.doi.org/10.1128/jcm.37.3.479-483.1999.
Pełny tekst źródłaBergmann, John S., Geoffrey Fish, and Gail L. Woods. "Evaluation of the BBL MGIT (Mycobacterial Growth Indicator Tube) AST SIRE System for Antimycobacterial Susceptibility Testing of Mycobacterium tuberculosis to 4 Primary Antituberculous Drugs." Archives of Pathology & Laboratory Medicine 124, no. 1 (2000): 82–86. http://dx.doi.org/10.5858/2000-124-0082-eotbmm.
Pełny tekst źródłaZhurilo, A. A., A. I. Barbova, Yu A. Cherednik, et al. "COMPARISON OF GENEXPERT MTB/RIF AND GENOTYPE SYSTEMS WITH MTBDRPLUS STRIPS FOR DETECTION OF MUTATIONS THAT ARE ASSOCIATED WITH M. TUBERCULOSIS RESISTANCE TO RIFAMPICIN IN TUBERCULOSIS." Ukrainian Pulmonology Journal 30, no. 4 (2022): 34–41. http://dx.doi.org/10.31215/2306-4927-2022-30-4-34-41.
Pełny tekst źródłaSakhelashvili, M. I., Z. I. Piskur, O. I. Sakhelashvili–Bil, et al. "Application of BI-V for contact children and adolescents from focies of multidrug-resistant tuberculous infection: evaluation of effectiveness." Tuberculosis, Lung Diseases, HIV Infection, no. 1 (March 15, 2023): 37–43. http://dx.doi.org/10.30978/tb-2023-1-37.
Pełny tekst źródłaSriram, D., K. Jyothi Mallika, and P. Yogeeswari. "Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity." Scientia Pharmaceutica 72, no. 1 (2004): 35–41. http://dx.doi.org/10.3797/scipharm.aut-04-04.
Pełny tekst źródłaCollins, L. A., M. N. Torrero, and S. G. Franzblau. "Green Fluorescent Protein Reporter Microplate Assay for High-Throughput Screening of Compounds againstMycobacterium tuberculosis." Antimicrobial Agents and Chemotherapy 42, no. 2 (1998): 344–47. http://dx.doi.org/10.1128/aac.42.2.344.
Pełny tekst źródłaArain, T. M., A. E. Resconi, M. J. Hickey, and C. K. Stover. "Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery." Antimicrobial Agents and Chemotherapy 40, no. 6 (1996): 1536–41. http://dx.doi.org/10.1128/aac.40.6.1536.
Pełny tekst źródłaWerngren, J., E. Sturegård, P. Juréen, K. Ängeby, S. Hoffner, and T. Schön. "Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions andpncAGene Sequencing." Antimicrobial Agents and Chemotherapy 56, no. 3 (2011): 1253–57. http://dx.doi.org/10.1128/aac.05894-11.
Pełny tekst źródłaPiersimoni, Claudio, Domenico Nista, Stefano Bornigia, and Giuseppina De Sio. "Evaluation of a New Method for Rapid Drug Susceptibility Testing of Mycobacterium avium Complex Isolates by Using the Mycobacteria Growth Indicator Tube." Journal of Clinical Microbiology 36, no. 1 (1998): 64–67. http://dx.doi.org/10.1128/jcm.36.1.64-67.1998.
Pełny tekst źródłaRuiz, P., F. J. Zerolo, and M. J. Casal. "Comparison of Susceptibility Testing of Mycobacterium tuberculosis Using the ESP Culture System II with That Using the BACTEC Method." Journal of Clinical Microbiology 38, no. 12 (2000): 4663–64. http://dx.doi.org/10.1128/jcm.38.12.4663-4664.2000.
Pełny tekst źródłaTolchkov, V., Y. Hodzhev, B. Tsafarova, et al. "Drug susceptibility testing of Mycobacterium tuberculosis using next generation sequencing and Mykrobe software." Journal of microbiology, epidemiology and immunobiology 98, no. 6 (2022): 697–705. http://dx.doi.org/10.36233/0372-9311-191.
Pełny tekst źródłaDavies, A. P., O. J. Billington, T. D. McHugh, D. A. Mitchison, and S. H. Gillespie. "Comparison of Phenotypic and Genotypic Methods for Pyrazinamide Susceptibility Testing with Mycobacterium tuberculosis." Journal of Clinical Microbiology 38, no. 10 (2000): 3686–88. http://dx.doi.org/10.1128/jcm.38.10.3686-3688.2000.
Pełny tekst źródłaKeren, Metin. "Drug Resistance Tests for Mycobacterium Tuberculosis and Compatibility between Tests; From Past to Today." Medical Science and Discovery 11, no. 2 (2024): 44–47. http://dx.doi.org/10.36472/msd.v11i2.1127.
Pełny tekst źródłaDomotenko, L. V., T. P. Morozova, I. G. Shemyakin, and A. P. Shepelin. "EXPERIENCE OF USING TB TEST KIT FOR THE RAPID DRUG SUSCEPTIBILITY TESTING OF M. TUBERCULOSIS." Russian Clinical Laboratory Diagnostics 65, no. 2 (2020): 122–30. http://dx.doi.org/10.18821/0869-2084-2020-65-2-122-130.
Pełny tekst źródłaKadhim, Afraa Ali, Mohammed Faraj AL-Marjan, Kadhim Ali Kadhim, and Ahmed Asmar Manki. "Isolation of Mycobacterium tuberculosis and testing their susceptibility to antimicrobial agents by using Bactec 960." Al Mustansiriyah Journal of Pharmaceutical Sciences 13, no. 1 (2013): 175–81. http://dx.doi.org/10.32947/ajps.v13i1.213.
Pełny tekst źródłaAlcaide, Fernando, Laura Calatayud, Miguel Santín, and Rogelio Martín. "Comparative In Vitro Activities of Linezolid, Telithromycin, Clarithromycin, Levofloxacin, Moxifloxacin, and Four Conventional Antimycobacterial Drugs against Mycobacterium kansasii." Antimicrobial Agents and Chemotherapy 48, no. 12 (2004): 4562–65. http://dx.doi.org/10.1128/aac.48.12.4562-4565.2004.
Pełny tekst źródłaDomotenko, L. V., T. P. Morozova, M. V. Khramov, and А. P. Shepelin. "Testing Susceptibility of M. tuberculosis to Second Line Anti-Tuberculosis Drugs Using the XDR Test in Clinical Trials and International Professional Testing Cycles." Tuberculosis and Lung Diseases 99, no. 8 (2021): 13–20. http://dx.doi.org/10.21292/2075-1230-2021-99-8-13-20.
Pełny tekst źródłaNosova, E. Yu, M. A. Sviridenko, A. A. Khakhalina, K. Yu Galkina, Yu D. Mikhailova, and S. G. Safonova. "Rapid diagnostics of tuberculosis using the Xpert MTB/Rif Ultra test." Tuberculosis and socially significant diseases 13, no. 1 (2025): 22–29. https://doi.org/10.54921/2413-0346-2025-13-1-22-29.
Pełny tekst źródłaManingi, Nontuthuko E., Luke T. Daum, John D. Rodriguez, et al. "Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates." Journal of Clinical Microbiology 53, no. 12 (2015): 3779–83. http://dx.doi.org/10.1128/jcm.01179-15.
Pełny tekst źródłaThuansuwan, Waraporn, Charoen Chuchottaworn, Chie Nakajima, Yasuhiko Suzuki, and Nuntaree Chaichanawongsaroj. "Biphasic Medium Using Nicotinamide for Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis." Antibiotics 13, no. 6 (2024): 563. http://dx.doi.org/10.3390/antibiotics13060563.
Pełny tekst źródłaMikhailova, Y. D., M. V. Makarova, L. Y. Krylova, et al. "Study of drug susceptibility of Mycobacterium tuberculosis to delamanid using BACTECTM MGITTM 960 automated system." Tuberculosis and socially significant diseases 12, no. 4 (2025): 25–35. https://doi.org/10.54921/2413-0346-2024-12-4-25-35.
Pełny tekst źródłaEl-Sayed Zaki, Maysaa, and Tarek Goda. "Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB." Tuberculosis 87, no. 2 (2007): 102–8. http://dx.doi.org/10.1016/j.tube.2006.05.002.
Pełny tekst źródłaPitaloka, Dian Ayu Eka, and Elin Yulinah Sukandar. "IN VITRO STUDY OF URSOLIC ACID COMBINATION FIRST-LINE ANTITUBERCULOSIS DRUGS AGAINST DRUG-SENSITIVE AND DRUG-RESISTANT STRAINS OF Mycobacterium tuberculosis." Asian Journal of Pharmaceutical and Clinical Research 10, no. 4 (2017): 216. http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16582.
Pełny tekst źródłaKim, Jae-Seok, Go-Eun Kang, Han-Sung Kim, Hyun Soo Kim, Wonkeun Song, and Kyu Man Lee. "Evaluation of Verigene Blood Culture Test Systems for Rapid Identification of Positive Blood Cultures." BioMed Research International 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/1081536.
Pełny tekst źródłaEliseev, P. I., E. I. Nikishova, A. Yu Krupskaya, V. I. Shtraukh, E. S. Khimova, and A. O. Maryandyshev. "Detection of <i>M. tuberculosis</i> Using Cartridge-Based Technology in Patients with Negative Sputum Microscopy Results in a Regional Laboratory." Tuberculosis and Lung Diseases 102, no. 2 (2024): 36–42. http://dx.doi.org/10.58838/2075-1230-2024-102-2-36-42.
Pełny tekst źródłaAndres, Sönke, Doris Hillemann, Sabine Rüsch-Gerdes, and Elvira Richter. "Occurrence ofrpoBMutations in Isoniazid-Resistant but Rifampin-Susceptible Mycobacterium tuberculosis Isolates from Germany." Antimicrobial Agents and Chemotherapy 58, no. 1 (2013): 590–92. http://dx.doi.org/10.1128/aac.01752-13.
Pełny tekst źródłaSingh, Ashok K., Shailendra K. Singh, Kavita Dhariyal, Ram Kumar, Amarendra Kumar, and Sudheer K. Singh. "Synthesis, Characterization and Antimycobacterial Activity of Phenanthrenequinone Thiosemicarbazones and their Ruthenium and Zinc Complexes." Asian Journal of Chemistry 33, no. 5 (2021): 983–88. http://dx.doi.org/10.14233/ajchem.2021.23127.
Pełny tekst źródłaOvsyankina, E. S., L. V. Panova, E. A. Krushinskaya, O. A. Piskunova, and F. G. Poluektova. "ON THE QUESTION OF REDUCED DURATION OF PULMONARY TB TREATMENT IN ADOLESCENTS WITH DRUG SUSCEPTIBILITY DETERMINATION DURING TREATMENT." Вестник ЦНИИТ 7, no. 2 (2023): 67–72. http://dx.doi.org/10.57014/2587-6678-2023-7-2-67-72.
Pełny tekst źródłaK, Kalaiselvi, Mangayarkarasi V, Gomathi Ns, Balaji S, Shivshankar R. Mane, and Raja Shunmugam. "LUCIFERASE REPORTER MYCOBACTERIOPHAGES FOR EVALUATING NORBORNENE-BASED ANTITUBERCULOSIS DRUG SUSCEPTIBILITY TESTING ON MYCOBACTERIUM TUBERCULOSIS." Asian Journal of Pharmaceutical and Clinical Research 10, no. 9 (2017): 406. http://dx.doi.org/10.22159/ajpcr.2017.v10i9.19660.
Pełny tekst źródłaA, Husain, Agarwal S, Jafar H, Awasthi S, and Prakash V. "Etiological agents causing paediatric sepsis and their antimicrobial susceptibility pattern at a tertiary care hospital." Journal of Medical and Scientific Research 13, no. 2 (2025): 131–35. https://doi.org/10.17727/jmsr.2024/13-23.
Pełny tekst źródłaHoward, Wanita J., Barry J. Buschelman, Martha J. Bale, Michael A. Pfaller, Frank P. Koontz, and Ronald N. Jones. "Vitek GPS card susceptibility testing accuracy using direct inoculation from Bactec 9240 blood culture bottles." Diagnostic Microbiology and Infectious Disease 24, no. 2 (1996): 109–12. http://dx.doi.org/10.1016/0732-8893(95)00273-1.
Pełny tekst źródłaChovatia, P. T., J. D. Akabari, P. K. Kachhadia, P. D. Zalavadia, and H. S. Joshi. "Synthesis and selective antitubercular and antimicrobial inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole derivatives." Journal of the Serbian Chemical Society 71, no. 7 (2006): 713–20. http://dx.doi.org/10.2298/jsc0607713c.
Pełny tekst źródłaKlymnyuk, Sergiy I., Leonid A. Hryshchuk, Mukola O. Vynnychuk, et al. "DIAGNOSTIC CHEMORESISTANT MYCOBACTERIUM TUBERCULOSIS IN THE TERNOPIL REGION OF UKRAINE." Wiadomości Lekarskie 73, no. 5 (2020): 959–62. http://dx.doi.org/10.36740/wlek202005122.
Pełny tekst źródłaHalperin, Ana V., José Luis Cortés Cuevas, Juan Antonio Del Castillo Polo, et al. "11. Evaluation of the Bact/alert® VIRTUO™ in Terms of Time to Detection, Performance, Workflow Efficiency and Impact on Patient Management, Compared to the BACTEC™ FX Automated Blood Culture System." Open Forum Infectious Diseases 7, Supplement_1 (2020): S7. http://dx.doi.org/10.1093/ofid/ofaa417.010.
Pełny tekst źródłaNnamani, Kenechi O., Chioma P. Nnamani, Kenechukwu K. Iloh, et al. "Bacterial isolates, antibiogram and outcomes of blood culture proven sepsis in neonates at a tertiary institution in South East Nigeria: a cross-sectional study." Therapeutic Advances in Infectious Disease 9 (January 2022): 204993612211224. http://dx.doi.org/10.1177/20499361221122479.
Pełny tekst źródłaFUURSTED, KURT. "Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of theM. tuberculosiscomplex." APMIS 101, no. 1-6 (1993): 154–59. http://dx.doi.org/10.1111/j.1699-0463.1993.tb00095.x.
Pełny tekst źródłaKurtoğlu, MG, H. Bozkurt, O. Tuncer, R. Kesli, and M. Berktas. "Distribution, Optimum Detection Time and Antimicrobial Susceptibility Rates of the Microorganisms Isolated from Blood Cultures over a 4-Year Time Period in a Turkish University Hospital and a Review of the International Literature." Journal of International Medical Research 36, no. 6 (2008): 1261–72. http://dx.doi.org/10.1177/147323000803600613.
Pełny tekst źródłaSakhelashvili, M. I., O. P. Kostyk, O. I. Sakhelashvili–Bil, Z. I. Piskur, and J. J. Didyk. "Peculiarities of the chemodrug resistance of M. tuberculosis to antituberculous medications among children and adolescents from multidrugresistant tuberculous focies." Tuberculosis, Lung Diseases, HIV Infection, no. 2 (June 17, 2022): 5–11. http://dx.doi.org/10.30978/tb-2022-2-5.
Pełny tekst źródłaDemers, Anne-Marie, Amour Venter, Sven O. Friedrich, et al. "Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System." Journal of Clinical Microbiology 54, no. 5 (2016): 1276–81. http://dx.doi.org/10.1128/jcm.03162-15.
Pełny tekst źródłaSuthum, Krairerk, Worada Samosornsuk, and Seksun Samosornsuk. "Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand." Journal of Infection in Developing Countries 14, no. 03 (2020): 268–76. http://dx.doi.org/10.3855/jidc.11974.
Pełny tekst źródłaYakrus, Mitchell A., Jeffrey Driscoll, Allison McAlister, et al. "Molecular and Growth-Based Drug Susceptibility Testing ofMycobacterium tuberculosisComplex for Ethambutol Resistance in the United States." Tuberculosis Research and Treatment 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/3404860.
Pełny tekst źródłaPfyffer, Gaby E., Donald A. Bonato, Adeleh Ebrahimzadeh, et al. "Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using the Radiometric BACTEC 460 Technique and the Proportion Method with Solid Media." Journal of Clinical Microbiology 37, no. 10 (1999): 3179–86. http://dx.doi.org/10.1128/jcm.37.10.3179-3186.1999.
Pełny tekst źródłaTilahun, Melaku, Teklu Wegayehu, Biniam Wondale, et al. "Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia." PLOS ONE 18, no. 9 (2023): e0285063. http://dx.doi.org/10.1371/journal.pone.0285063.
Pełny tekst źródłaShifman, Ohad, Tamar Aminov, Moshe Aftalion, et al. "Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures." Microorganisms 9, no. 5 (2021): 1055. http://dx.doi.org/10.3390/microorganisms9051055.
Pełny tekst źródłaChedore, Pamela, Lina Bertucci, Joyce Wolfe, Meenu Sharma, and Frances Jamieson. "Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility ofMycobacterium tuberculosisto Pyrazinamide." Journal of Clinical Microbiology 48, no. 1 (2009): 300–301. http://dx.doi.org/10.1128/jcm.01775-09.
Pełny tekst źródłaBorek, Anna, Anna Zabost, Agnieszka Głogowska, Dorota Filipczak, and Ewa Augustynowicz-Kopeć. "New RAPMYCOI SensititreTM Antimicrobial Susceptibility Test for Atypical Rapidly Growing Mycobacteria (RGM)." Diagnostics 12, no. 8 (2022): 1976. http://dx.doi.org/10.3390/diagnostics12081976.
Pełny tekst źródłaKania, Katarzyna, Katarzyna Wójcik, Kamil Drożdż, and Karolina Klesiewicz. "Utility of Rapid Molecular Assays for Detecting Multidrug-Resistant Mycobacterium tuberculosis in Extrapulmonary Samples." Diagnostics 15, no. 9 (2025): 1113. https://doi.org/10.3390/diagnostics15091113.
Pełny tekst źródłaKaya, Eyyüp, Hamide Kaya, and Candan Öztürk. "Antibiotic susceptibilities and microorganisms isolated from blood cultures of inpatients in a secondary state hospital in Türkiye." Cukurova Medical Journal 50, no. 1 (2025): 1–10. https://doi.org/10.17826/cumj.1548878.
Pełny tekst źródłaAlgazina, V. V., T. G. Smirnova, V. V. Romanov, and A. E. Ergeshov. "The incidence of M. tuberculosis resistance to linezolid and bedaquiline in patients for the period 2011-2022." Tuberculosis and socially significant diseases 12, no. 3 (2024): 20–25. https://doi.org/10.54921/2413-0346-2024-12-3-20-25.
Pełny tekst źródła